Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Long-term survival after cardiac arrest in hypertrophic cardiomyopathy.

Maron BJ, Haas TS, Shannon KM, Almquist AK, Hodges JS.

Heart Rhythm. 2009 Jul;6(7):993-7. doi: 10.1016/j.hrthm.2009.03.014.

PMID:
19497790
2.

Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.

Pokorski RJ.

J Insur Med. 2002;34(1):43-60. Review.

PMID:
15303593
3.

[Interventional treatment in hypertrophic cardiomyopathy].

Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.

Herz. 2005 Mar;30(2):102-10. Review. German.

PMID:
15875098
4.

Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P.

J Cardiovasc Electrophysiol. 2008 Oct;19(10):1118-26. doi: 10.1111/j.1540-8167.2008.01147.x. Review.

PMID:
18384577
6.

Prognostic factors of the results of cardiopulmonary resuscitation in a cardiology hospital.

Timerman A, Sauaia N, Piegas LS, Ramos RF, Gun C, Santos ES, Bianco AC, Sousa JE.

Arq Bras Cardiol. 2001 Aug;77(2):142-60. Review. English, Portuguese.

7.

Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.

Cotiga D, Ehlert F, Sherrid M.

Anadolu Kardiyol Derg. 2006 Dec;6 Suppl 2:55-60. Review.

8.

[Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey].

Reith S, Klues HG.

Z Kardiol. 2003 Apr;92(4):283-93. Review. German.

PMID:
12707787
9.

[Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review].

Kukla P, Petkow-Dimitrow P, Jastrzebski M, Bednarek J, Lelakowski J, Bryniarski L.

Kardiol Pol. 2009 Jul;67(7):774-80; discussion 781. Review. Polish.

10.

New trends in treatment of hypertrophic cardiomyopathy.

Hagège AA, Desnos M.

Arch Cardiovasc Dis. 2009 May;102(5):441-7. doi: 10.1016/j.acvd.2009.03.008. Review.

11.

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.

Miller MA, Gomes JA, Fuster V.

Nat Clin Pract Cardiovasc Med. 2007 Dec;4(12):667-76. Review.

PMID:
18033231
12.

Hypertrophic cardiomyopathy: a review of etiology and treatment.

Jurynec J.

J Cardiovasc Nurs. 2007 Jan-Feb;22(1):65-73; quiz 74-5. Review.

PMID:
17224700
13.

Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Cecchi F.

Curr Cardiol Rep. 2001 Mar;3(2):141-6. Review.

PMID:
11177672
14.

Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America?

Östman-Smith I, Rossano JW, Shaddy RE.

Curr Opin Cardiol. 2013 Mar;28(2):130-8. doi: 10.1097/HCO.0b013e32835dd020. Review.

PMID:
23348710
15.

Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.

Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM Jr.

J Am Coll Cardiol. 2009 Nov 24;54(22):1993-2000. doi: 10.1016/j.jacc.2009.07.039. Review.

16.

Does myectomy convey survival benefit in hypertrophic cardiomyopathy?

Woo A, Rakowski H.

Heart Fail Clin. 2007 Jul;3(3):275-88. Review.

PMID:
17723936
17.

Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment.

Musat D, Sherrid MV.

Anadolu Kardiyol Derg. 2006 Dec;6 Suppl 2:9-17. Review.

18.

Hypertrophic cardiomyopathy in childhood.

Maron BJ.

Pediatr Clin North Am. 2004 Oct;51(5):1305-46. Review.

PMID:
15331286
19.

Current status of implantable cardioverter-defibrillator therapy in heart failure.

Can I, Tholakanahalli VN.

Curr Heart Fail Rep. 2009 Sep;6(3):199-209. Review.

PMID:
19723462
20.

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.

McKenna WJ, Behr ER.

Heart. 2002 Feb;87(2):169-76. Review. No abstract available.

Items per page

Supplemental Content

Support Center